A detailed history of Advisor Group Holdings, Inc. transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 12,440 shares of CODX stock, worth $9,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,440
Previous 12,440 -0.0%
Holding current value
$9,205
Previous $15,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.01 - $1.7 $696 - $1,173
690 Added 5.87%
12,440 $15,000
Q1 2024

May 10, 2024

BUY
$1.06 - $1.42 $11,130 - $14,910
10,500 Added 840.0%
11,750 $13,000
Q4 2023

Feb 12, 2024

SELL
$1.0 - $1.5 $910 - $1,365
-910 Reduced 42.13%
1,250 $1,000
Q3 2023

Nov 13, 2023

BUY
$1.03 - $1.85 $494 - $888
480 Added 28.57%
2,160 $2,000
Q2 2023

Aug 10, 2023

SELL
$1.04 - $1.64 $3,068 - $4,838
-2,950 Reduced 63.71%
1,680 $1,000
Q1 2023

May 12, 2023

SELL
$1.39 - $3.24 $2,938 - $6,849
-2,114 Reduced 31.35%
4,630 $6,000
Q4 2022

Feb 10, 2023

SELL
$2.32 - $3.68 $1,276 - $2,024
-550 Reduced 7.54%
6,744 $16,000
Q3 2022

Nov 14, 2022

SELL
$2.87 - $7.01 $2,674 - $6,533
-932 Reduced 11.33%
7,294 $24,000
Q1 2022

May 04, 2022

SELL
$5.03 - $9.61 $23,238 - $44,398
-4,620 Reduced 35.96%
8,226 $54,000
Q3 2021

Nov 05, 2021

SELL
$7.48 - $11.38 $19,814 - $30,145
-2,649 Reduced 17.1%
12,846 $124,000
Q2 2021

Aug 02, 2021

SELL
$7.16 - $9.56 $2,964 - $3,957
-414 Reduced 2.6%
15,495 $129,000
Q1 2021

May 13, 2021

SELL
$8.52 - $19.21 $67,623 - $152,469
-7,937 Reduced 33.28%
15,909 $152,000
Q4 2020

Feb 10, 2021

SELL
$9.3 - $15.19 $460,071 - $751,449
-49,470 Reduced 67.48%
23,846 $222,000
Q3 2020

Nov 12, 2020

BUY
$8.24 - $30.8 $406,734 - $1.52 Million
49,361 Added 206.06%
73,316 $1 Million
Q2 2020

Aug 14, 2020

BUY
$7.46 - $23.42 $75,644 - $237,478
10,140 Added 73.4%
23,955 $463,000
Q1 2020

May 18, 2020

BUY
$0.91 - $17.81 $12,571 - $246,045
13,815 New
13,815 $108,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $25M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.